Cargando…
Therapeutic Plasma Exchange and Multiple Sclerosis Dysregulations: Focus on the Removal of Pathogenic Circulatory Factors and Altering Nerve Growth Factor and Sphingosine-1-Phosphate Plasma Levels
Multiple sclerosis (MS) is predominantly an immune-mediated disease of the central nervous system (CNS) of unknown etiology with a possible genetic predisposition and effect of certain environmental factors. It is generally accepted that the disease begins with an autoimmune inflammatory reaction ta...
Autores principales: | Tonev, Dimitar, Momchilova, Albena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605592/ https://www.ncbi.nlm.nih.gov/pubmed/37886933 http://dx.doi.org/10.3390/cimb45100489 |
Ejemplares similares
-
Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology
por: Tonev, Dimitar G., et al.
Publicado: (2023) -
Our Clinical Experience in the Treatment of Myasthenia Gravis Acute Exacerbations with a Novel Nanomembrane-Based Therapeutic Plasma Exchange Technology
por: Tonev, Dimitar, et al.
Publicado: (2022) -
Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
por: Kowalski, Greg M., et al.
Publicado: (2013) -
Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients
por: Momchilova, Albena, et al.
Publicado: (2022) -
Sphingosine 1-Phosphate Distribution in Human Plasma: Associations with Lipid Profiles
por: Hammad, Samar M., et al.
Publicado: (2012)